SUNLAND: a randomized, double-blinded phase II GERCOR trial of sunitinib versus placebo and lanreotide in patients with advanced progressive midgut neuroendocrine tumors
SUNLAND:一项随机、双盲 II 期 GERCOR 试验,比较舒尼替尼与安慰剂和兰瑞肽治疗晚期进展性中肠神经内分泌肿瘤患者的疗效
期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359241290140
Hammel, Pascal; Smith, Denis; Afchain, Pauline; Dominguez-Tinajero, Sophie; Seitz, Jean-François; Lievre, Astrid; Van Cutsem, Eric; Assenat, Eric; Di Fiore, Frédéric; Peeters, Marc; Sobhani, Iradj; Raymond, Eric; Charton, Emilie; Vernerey, Dewi; De Mestier, Louis; Lombard-Bohas, Catherine